COVID‐19 pandemic, vaccine nationalism and counterfeit products: Discourse and emerging research themes

Abstract

Although “vaccine nationalism” and vaccine diplomacy have thus far typified the COVID‐19 vaccine rollouts around the globe, there remain limited scholarly insights on global vaccine distribution strategies. This research note (RN) examines the global vaccine distribution strategies and implications for public policy and governments. In conceptualizing the global vaccine distribution strategies into three competing perspectives (i.e., “vaccine nationalism,” vaccine diplomacy, and global initiative), this article highlights the divergent effects of different approaches in terms of ushering elements of nationalism and ethnocentrism. By contextualizing the discourse on the COVID‐19 pandemic into the three competing perspectives and highlighting the role of pharmaceutical companies and COVID‐19 vaccine passport, the study also offers pathways for further examination of the subject incorporating the contextual conditions.

The role of Trade policy in enabling access to COVID-19 vaccines

“…The issue of vaccines distribution in the moment they have appeared, provoked other issues and implications for public policies and governments of many countries. Global distribution of vaccines could be monitored from three aspects concerning three mutually competing distribution strategies: vaccine nationalism, vaccine diplomacy and global initiative [19]. Some authors have documented the existence of the small club of vaccine`s producers, caused by their production delays at the beginning of the 2021.…”

Market violence through destructive entrepreneurship: Assessing institutional responses to the proliferation of counterfeit traditional and alternative medicines in Ghana

“…It is instructive to note that since the outbreak of the coronavirus disease (COVID-19 pandemic), there have been several reports of unregistered and counterfeit TAM being used to treat the disease globally [ [24] , [25] , [26] , [27] ]. Regrettably, there is a market for such goods because of a lack of access to regulated and controlled medicines.…”

Mental health at the workplace, person-organization-fit and labor productivity growth: evidence from the Egyptian soap and detergents industry during COVID-19

“…Significant implications for management practice are also highlighted, elucidating the role of the first-line supervisors in fostering the P.O-fit dimensions, controlling MHIW and retaining WP growth during COVID-19. This study also extends the ongoing scholarly discourse of the COVID-19 pandemic (Adekoya et al ., 2022; Amankwah-Amoah, 2022; Amankwah-Amoah and Hinson, 2022; Gashi et al ., 2022; Rozman and Tominc, 2022; Rožman and Čančer, 2022; Kundu et al. , 2022) by integrating and incorporating insights on mental health at the workplace to enrich the current literature.…”